BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9253329)

  • 1. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
    Berneis K; Ninnis R; Girard J; Frey BM; Keller U
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2528-34. PubMed ID: 9253329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans.
    Oehri M; Ninnis R; Girard J; Frey FJ; Keller U
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E552-8. PubMed ID: 8928758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL; Jackson NC; Shojaee-Moradie F; Jones RH; Russell-Jones DL; Sönksen PH; Dunger DB; Umpleby AM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R; Ninnis R; Keller U
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
    Murphy MG; Plunkett LM; Gertz BJ; He W; Wittreich J; Polvino WM; Clemmons DR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
    Mauras N; Horber FF; Haymond MW
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
    Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
    JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
    Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER
    Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
    Skjaerbaek C; Frystyk J; Møller J; Christiansen JS; Orskov H
    Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.
    Vahl N; Møller N; Lauritzen T; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3612-8. PubMed ID: 9360515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR; Smith-Banks A; Underwood LE
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M; Hauri C; Zapf J
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.